1. Frohman EM, Frohman TC, Zee DS, McColl R, Galetta S. The neuro-ophthalmology of multiple sclerosis. The Lancet Neurology. 2005;4(2):111-21.
2. Greenberg D, Aminoff M, Simon R. Clinical Neurology 8/E: McGraw Hill Professional; 2012.
3. Sakai RE, Feller DJ, Galetta KM, Galetta SL, Balcer LJ. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. Journal of neuro-ophthalmology: the official journal of the North American Neuro-Ophthalmology Society. 2011;31(4):362-73.
4. Adams R, Victor M, Ropper A. Principle of neurology 7th ed. McGrawhill; 2005.
5. Fischer LG. The ocular manifestations of multiple sclerosis. Journal of the American Optometric Association. 1977;48(12):1511-5.
6. Chen L, Gordon LK. Ocular manifestations of multiple sclerosis. Current opinion in ophthalmology. 2005;16(5):315-20.
7. JM R. Ocular problems in early stages of multiple sclerosis. Bull soc belge ophtalmol. 2009;313:65-8.
8. Alroughani R, Ahmed SF, Al-Hashel J. Demographics and clinical characteristics of multiple sclerosis in Kuwait. European neurology. 2014;72(3-4):181-5.
9. El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y. Multiple sclerosis in Jordan: A clinical and epidemiological study. Journal of neurology. 2006;253(9):1210-6.
10. Miller DH, Fazekas F, Montalban X, Reingold SC, Trojano M. Pregnancy, sex and hormonal factors in multiple sclerosis. Multiple sclerosis. 2014;20(5):527-36.
11. Granieri E. Exogeneous factors in the aetiology of multiple sclerosis. Journal of neurovirology. 2000;6 Suppl 2:S141-6.
12. Fernandez-Perez MJ, Barakat O, Garcia-Moreno JM, Lucas M, Navarro G, Gata JM, et al. [Clinical features of familial multiple sclerosis in Spain]. Revista de neurologia. 1999;29(8):693-6.
13. Anton Aranda E, Martinez-Lage JM, Maravi Petri E, Gallego Cullere J, de Castro P, Villanueva Eusa JA. [Epidemiology and clinical evolutionary aspects of multiple sclerosis in Navarra]. Neurologia (Barcelona, Spain). 1991;6(5):160-9.
14. Hoang PD, Gandevia SC, Herbert RD. Prevalence of joint contractures and muscle weakness in people with multiple sclerosis. Disability and rehabilitation. 2014;36(19):1588-93.
15. Sidhom Y, Damak M, Riahi A, Hizem Y, Mrissa R, Mhiri C, et al. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course? Journal of the neurological sciences. 2014;343(1-2):110-4.